91 related articles for article (PubMed ID: 12063398)
1. Molecular cytogenetic investigations define a subgroup of thyroid adenomas with 2p21 breakpoints clustered to a region of less than 450 kb.
Bol S; Belge G; Rippe V; Bullerdiek J
Cytogenet Cell Genet; 2001; 95(3-4):189-91. PubMed ID: 12063398
[TBL] [Abstract][Full Text] [Related]
2. Breakpoints of 19q13 translocations of benign thyroid tumors map within a 400 kilobase region.
Belge G; Garcia E; Rippe V; Fusco A; Bartnitzke S; Bullerdiek J
Genes Chromosomes Cancer; 1997 Oct; 20(2):201-3. PubMed ID: 9331571
[TBL] [Abstract][Full Text] [Related]
3. Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas.
Rippe V; Drieschner N; Meiboom M; Murua Escobar H; Bonk U; Belge G; Bullerdiek J
Oncogene; 2003 Sep; 22(38):6111-4. PubMed ID: 12955091
[TBL] [Abstract][Full Text] [Related]
4. Delineation of a 150-kb breakpoint cluster in benign thyroid tumors with 19q13.4 aberrations.
Belge G; Rippe V; Meiboom M; Drieschner N; Garcia E; Bullerdiek J
Cytogenet Cell Genet; 2001; 93(1-2):48-51. PubMed ID: 11474178
[TBL] [Abstract][Full Text] [Related]
5. From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization.
Chen X; Knauf JA; Gonsky R; Wang M; Lai EH; Chissoe S; Fagin JA; Korenberg JR
Am J Hum Genet; 1998 Aug; 63(2):625-37. PubMed ID: 9683604
[TBL] [Abstract][Full Text] [Related]
6. The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas.
Rippe V; Dittberner L; Lorenz VN; Drieschner N; Nimzyk R; Sendt W; Junker K; Belge G; Bullerdiek J
PLoS One; 2010 Mar; 5(3):e9485. PubMed ID: 20209130
[TBL] [Abstract][Full Text] [Related]
7. A KRAB zinc finger protein gene is the potential target of 19q13 translocation in benign thyroid tumors.
Rippe V; Belge G; Meiboom M; Kazmierczak B; Fusco A; Bullerdiek J
Genes Chromosomes Cancer; 1999 Nov; 26(3):229-36. PubMed ID: 10502321
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin.
Drieschner N; Belge G; Rippe V; Meiboom M; Loeschke S; Bullerdiek J
Thyroid; 2006 Nov; 16(11):1091-6. PubMed ID: 17123335
[TBL] [Abstract][Full Text] [Related]
9. Detection of numerical alterations for chromosomes 7 and 12 in benign thyroid lesions by in situ hybridization. Histological implications.
Criado B; Barros A; Suijkerbuijk RF; Weghuis DO; Seruca R; Fonseca E; Castedo S
Am J Pathol; 1995 Jul; 147(1):136-44. PubMed ID: 7604875
[TBL] [Abstract][Full Text] [Related]
10. Physical mapping of chromosome 12q breakpoints in lipoma, pleomorphic salivary gland adenoma, uterine leiomyoma, and myxoid liposarcoma.
Schoenmakers EF; Kools PF; Mols R; Kazmierczak B; Bartnitzke S; Bullerdiek J; Dal Cin P; De Jong PJ; Van den Berghe H; Van de Ven WJ
Genomics; 1994 Mar; 20(2):210-22. PubMed ID: 8020967
[TBL] [Abstract][Full Text] [Related]
11. Aberrations of chromosome 19. Do they characterize a subtype of benign thyroid adenomas?
Belge G; Thode B; Bullerdiek J; Bartnitzke S
Cancer Genet Cytogenet; 1992 May; 60(1):23-6. PubMed ID: 1591702
[TBL] [Abstract][Full Text] [Related]
12. Does conventional cytogenetics detect the real frequency of 19q13 aberrations in benign thyroid lesions? A survey of 38 cases.
Meiboom M; Belge G; Bol S; El-Aouni C; Schoenmakers EF; Bullerdiek J
Cancer Genet Cytogenet; 2003 Oct; 146(1):70-2. PubMed ID: 14499699
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13-q15 implicated in various solid tumors.
Van de Ven WJ; Schoenmakers EF; Wanschura S; Kazmierczak B; Kools PF; Geurts JM; Bartnitzke S; Van den Berghe H; Bullerdiek J
Genes Chromosomes Cancer; 1995 Apr; 12(4):296-303. PubMed ID: 7539285
[TBL] [Abstract][Full Text] [Related]
14. Mapping of the translocation breakpoints of primary pleomorphic adenomas and lipomas within a common region of chromosome 12.
Wanschura S; Belge G; Stenman G; Kools P; Dal Cin P; Schoenmakers E; Huysmans C; Van den Berghe H; Bartnitzke S; Van de Ven WJ; Bullerdiek J
Cancer Genet Cytogenet; 1996 Jan; 86(1):39-45. PubMed ID: 8616784
[TBL] [Abstract][Full Text] [Related]
15. Interphase fluorescence in situ hybridization analysis detects a much higher rate of thyroid tumors with clonal cytogenetic deviations of the main cytogenetic subgroups than conventional cytogenetics.
Drieschner N; Rippe V; Laabs A; Dittberner L; Nimzyk R; Junker K; Rommel B; Kiefer Y; Belge G; Bullerdiek J; Sendt W
Cancer Genet; 2011 Jul; 204(7):366-74. PubMed ID: 21872823
[TBL] [Abstract][Full Text] [Related]
16. [Cytogenetic changes in benign thyroid gland hyperplasias and adenomas correlated with histology].
Belge G; Roque L; Thode B; Fonseca E; Soares J; Clode A; Bartnitzke S; Castedo S; Bullerdiek J
Verh Dtsch Ges Pathol; 1997; 81():151-6. PubMed ID: 9474866
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic investigations of 340 thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology.
Belge G; Roque L; Soares J; Bruckmann S; Thode B; Fonseca E; Clode A; Bartnitzke S; Castedo S; Bullerdiek J
Cancer Genet Cytogenet; 1998 Feb; 101(1):42-8. PubMed ID: 9460499
[TBL] [Abstract][Full Text] [Related]
18. A 2-Mb YAC contig and physical map covering the chromosome 8q12 breakpoint cluster region in pleomorphic adenomas of the salivary glands.
Kas K; Röijer E; Voz M; Meyen E; Stenman G; Van de Ven WJ
Genomics; 1997 Aug; 43(3):349-58. PubMed ID: 9268638
[TBL] [Abstract][Full Text] [Related]
19. A domain of the thyroid adenoma associated gene (THADA) conserved in vertebrates becomes destroyed by chromosomal rearrangements observed in thyroid adenomas.
Drieschner N; Kerschling S; Soller JT; Rippe V; Belge G; Bullerdiek J; Nimzyk R
Gene; 2007 Nov; 403(1-2):110-7. PubMed ID: 17889454
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic abnormalities in thyroid adenomas.
Antonini P; Vénuat AM; Linares G; Caillou B; Schlumberger M; Travagli JP; Berger R; Parmentier C
Cancer Genet Cytogenet; 1991 Apr; 52(2):157-64. PubMed ID: 2021917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
